BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


Frances Bornstein Associate Director to head its Financial Communications and Investors Relations Practice

London, Manchester, Munich, 22nd September 2006 Northbank Communications Limited, the leading consultancy in science and life science communications, announces the appointment of Frances Bornstein as Associate Director, to head its Financial Communications and Investor Relations practice.

Most recently, Frances ran a consulting business in Switzerland, most notably advising Intercell through its IPO on the Vienna Stock Exchange, including its IR program. Previous to that, she worked at the SWX Swiss Exchange, most latterly as Vice President and Head of Issuers & Investor Relations. At SWX she advised companies for over five years on new issues and aspects of being a public company. Frances was responsible for the Positioning and Marketing of the equity market and for the development of all life science related activities. Frances also headed the strategic segmentation project for the equity market which included the launch of Small and Mid Cap indices (SPI EXTRA, SMIM) and the SWX Life Science indices (SXI LIFE, SXI BM). Her early career included broadcast and news agency journalism covering business and finance, in Munich and Zurich. She has a degree in Business specializing in Marketing and Strategic Management.

At Northbank Frances will be based in its London offices, working with current clients and growing its Financial Communications and IR business both in the UK and In Europe. She replaces Emma Palmer who left in July to join ING Wholesale Banking.

Commenting on Frances’ appointment, Sue Charles, CEO of Northbank, said: “Northbank has been steadily growing its Financial Communications practice with a focus on Life Science companies and I am delighted that Frances has joined the team to further establish our client base and reputation in this area.”

- ends -

For further information please contact:                

Sue Charles, CEO         +44 (0)20 3008 7550      s.charles@northbankcommunications.com    

Frances Bornstein - New Associate Director at Northbank Communications 

For a high resolution photograph, please contact:

Vicky Pateman, Marketing Assistant/PA            +44 (0)20 3008 7560        v.pateman@northbankcommunications.com  

Notes  

Northbank Communications Ltd - www.northbankcommunications.com

Northbank Communications, a full service PR and communications consultancy, focused on serving science-based companies and organisations, with a strong focus in the life science industry. Northbank has specialist practices in Corporate, Marketing and Financial Communications, and an in house design studio. 

Northbank Communications Limited was formed through the merger of Charles Consultants into STMP Marketing Solutions Ltd in November 2002 and operates from offices in London and Congleton (near Manchester) in the UK, and Munich Germany. The Company employs 31 staff with an annual turnover in excess £2.5m (€3.6m). In 2005 Northbank was finalist in the PR Week Specialist Consultancy of the Year Award and, in the 2006 PR Week League Table, was ranked 108th overall and 16th in the Healthcare Top 50, achieving one of the fastest growth rates at 81%. In 2006 it was also finalist in the CIPR Awards for Excellence in both the corporate and healthcare categories.

 

 

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.